Kolexia
Haydar Mazen
Oncologie médicale
Hopital Prive Du Val D Yerres
Yerres, France
73 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du pancréas Tumeurs des voies biliaires Cholangiocarcinome Prolapsus Lymphome malin non hodgkinien Cellules tumorales circulantes Maladies vasculaires Troubles de la veille et du sommeil Kystes

Industries

A+A
18 collaboration(s)
Dernière en 2023
IQVIA
12 collaboration(s)
Dernière en 2023
MSD
6 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2023

Dernières activités

Transanal small bowel evisceration: A case report and literature review.
International journal of surgery case reports   04 janvier 2024
A retrospective study of patient-tailored FOLFIRINOX as a first-line chemotherapy for patients with advanced biliary tract cancer.
BMC cancer   03 juin 2020
The day after: correlates of patient-reported outcomes with actigraphy-assessed sleep in cancer patients at home (inCASA project).
Sleep   04 mai 2020
Home-Based e-Health Platform for Multidimensional Telemonitoring of Symptoms, Body Weight, Sleep, and Circadian Activity: Relevance for Chronomodulated Administration of Irinotecan, Fluorouracil-Leucovorin, and Oxaliplatin at Home-Results From a Pilot Study.
JCO clinical cancer informatics   04 octobre 2019
Patient-tailored FOLFIRINOX as first line treatment of patients with advanced pancreatic adenocarcinoma.
Medicine   07 mai 2019
FOLFIRINOX as a first-line chemotherapy for patients (pts) with advanced biliary tract cancer (BTC)
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018
Circadian rest-activity rhythm as an objective biomarker of patient-reported outcomes in patients with advanced cancer.
Cancer medicine   07 août 2018
Patient-tailored FOLFIRINOX in the first-line treatment of patients (pts) with advanced pancreatic cancer (PC).
2018 Gastrointestinal Cancers Symposium   26 février 2018
Multidimensional telemonitoring of cancer patients (pts) receiving chronomodulated (chrono) Irinotecan (I), 5-fluorouracil (F), leucovorin (L) and oxaliplatin (O; chronoIFLO4) combination at home
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project.
Journal of medical Internet research   25 novembre 2016